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Background: The right to prescribe drugs remains a contentious issue within the chiropractic profession.
Nevertheless, drug prescription by manual therapy providers is currently an important topic. Notably,
physiotherapists in the United Kingdom were recently granted limited independent prescribing rights. Reports
suggest that physiotherapists in Australia now want those same rights, and as such a review of chiropractors’
general attitudes toward drug prescription is needed.
Objective: To examine the literature concerning chiropractors’ attitudes toward drug prescription rights and to
compare the opinions of chiropractors currently licensed to prescribe medication with those in the profession
who are not.
Methods: This was a narrative review, consisting of a formal literature search and summary of included articles.
Electronic databases searched included the Cumulative Index to Nursing and Allied Health Literature, PubMed,
and the Index to Chiropractic Literature. Inclusion criteria consisted of prospective studies published in English
in peer-reviewed journals. Studies were required to contain data on chiropractors’ opinions toward medication
prescription rights.
Results: Of 33 articles identified, a total of seven surveys were included in the review. Of these, there was a
general split in opinion among chiropractors regarding the right to prescribe drugs in chiropractic practice.
Those supportive of prescribing rights favoured a limited number of over-the-counter and/or prescription-based
medications such as analgesics, anti-inflammatories, and muscle relaxants. When questioned on full prescribing
rights, however, chiropractors were generally opposed. In jurisdictions where chiropractors are currently licensed
to prescribe from a limited formulary, such as in Switzerland, the majority perceived this right as an advantage
for the profession. Moreover, continuing education in pharmacology was viewed as a necessary component of
this privilege.
Conclusions: Based on the literature to date there is a general split in chiropractors’ attitudes toward drug
prescription rights. This split is most pronounced in countries where chiropractors are not licensed to prescribe
medications. Notwithstanding, this is an important topic in chiropractic currently and warrants both further
discussion and research to determine future directions and the implications of either pursuit or denial of
prescription rights by chiropractors. Future surveys and/or qualitative studies of other chiropractors’ opinions
toward gaining prescription privileges would be timely.
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Table 1 Chiropractic formularies in Switzerland [16] and
New Mexico, USA [17]
Switzerland New Mexico, USA
Analgesics Hormones for topical, sublingual, oral use
• acetaminophen • estradiol
• becetamol • progesterone
• ben-u-ron • testosterone
• dafalgan • desiccated thyroid
• dolprone 500 Muscle relaxers; cyclobenzaprine
• minalgin NSAIDs – prescription strength
• Novalgin • ibuprofen
• treuphadol • naproxen
NSAIDs Prescription medications for topical use
• aspirin • NMDC Ca2 dextromethorphan
• ibuprofen • NSAIDs (ketoprofen, piroxicam,
naproxen, ibuprofen, diclofenac)
• naproxen • muscle relaxants; cyclobenzaprine
• diclofenac • sodium channel antagonist; lidocaine
• piroxicam
• indomethacin Homeopathics requiring prescription
Other substances by injection
• sterile water
• sterile saline




• homeopathic for injection
Glutathione for inhalation
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Throughout most of its nearly 120-year history the
chiropractic profession has presented itself as a drugless,
non-surgical healing profession. Since 1999, the World
Federation of Chiropractic (WFC) has maintained the
following policy statement on the use of prescription
drugs: “…for reasons of chiropractic principle, patient
welfare and interdisciplinary cooperation the practice of
chiropractic does not include the use of prescription
drugs, and chiropractic patients who may benefit from
prescription drugs should be referred, where appropriate,
to a medical doctor or other suitably qualified health
care practitioner” [1]. From the WFC ‘Consultation on
Identity’ survey in 2004, positioning of the profession
as ‘non-drug, non-surgical health care’ was viewed by
chiropractors worldwide as integral to how the pro-
fession should be perceived by the general public [2].
Regardless, contention over the right to prescribe
drugs in chiropractic has existed in some countries
for decades [3-14].
In or about 1989, four chiropractic-licensing boards in
the United States (including Illinois, Florida, Vermont,
and Texas) were actively lobbying for drug prescription
rights [3]. In response to concerned members who had
defected to the International Chiropractors Association
(ICA), the American Chiropractic Association (ACA)
set out to clarify its position on pharmaceuticals in
chiropractic practice [4]. At their June 1989 national
convention, the ACA delegates voted “decisively” to
insert the following passage into their ‘Master Plan’:
“Chiropractic is a drug-free, non-surgical science and,
as much, does not include pharmaceuticals or incisive
surgery” [4]. However, the ACA would not promote le-
gislation to prohibit chiropractic state laws from in-
cluding drug prescription within their respective
scopes of practice [3,4]. As a consequence, the profes-
sion was further polarized on this issue in the United
States [3-9]. Numerous commentaries on this topic
have appeared in the peer-reviewed literature, both in
favour of [10-14] and against [3-10] the prescription
of drugs by chiropractors.
Currently, there are only two jurisdictions in the world
where drug prescription has been incorporated into the
scope of chiropractic practice. Since 1995 chiroprac-
tors in Switzerland have been licensed to prescribe
from a limited formulary of over-the-counter (OTC)
non-steroidal anti-inflammatory drugs (NSAIDs) and
analgesics [15,16], while chiropractors in New Mexico,
USA gained similar privileges in 2009 [17] (Table 1).
Recently, other health care professions have also been
gaining prescriptive rights. In a landmark ruling on
July 24, 2012 (after nearly a decade of campaigning),
physiotherapists in the United Kingdom were granted
limited independent prescribing rights [18]. They joined thenursing, pharmacy, optometry, and podiatry professions
who have been given similar privileges. It appears that
Australian physiotherapists may also wish to expand
their scopes of practice to include drug prescription
rights as well [19].
The purpose of this review is to examine the literature
regarding chiropractors’ attitudes toward the inclusion
of drug prescription rights in the chiropractic scope of
practice. This review also seeks to compare the opin-
ions of chiropractors currently licensed to prescribe
medication with those in the profession who are not.
The results of this study are important as they may
have implications regarding future research and policy
discussion relating to this topic. For the purposes of
this review, drugs or medicines are defined as prescrip-
tion and/or OTC pharmaceuticals, and do not include
vitamins, minerals, or other nutritional supplements or
homeopathic remedies.




A search was conducted of the Cumulative Index to
Nursing and Allied Health Literature (CINAHL), PubMed,
and the Index to Chiropractic Literature (ICL) databases,
without time limits to October 19, 2013. The searches
were limited to human studies published in English in
peer-reviewed journals. In all three databases, the trun-
cated word ‘chiropract*’ was combined using the Boolean
operator, ‘AND’ with a variety of medical subject
headings (MeSH) and text words relevant to the topic
(see Appendix 1 for the complete search strategy).
‘Switzerland’ and ‘New Mexico’, the two jurisdictions
where chiropractors are currently licensed to prescribe
medication, were also used as key words in the database
searches. Reference searching of any retrieved articles was
undertaken, as was personal contact with authors known
to have expertise on this subject to determine if they were
aware of potentially relevant references.
Article selection criteria
To select potentially relevant papers, the retrieved citation
titles were scanned, followed by a review of their abstracts.
Full manuscripts of those that appeared to meet the re-
view criteria were then retrieved for further analysis.
The inclusion and exclusion criteria for this review are
displayed in Table 2.
Appraisal methods
As this was a narrative review, included articles were not
evaluated for their quality. However, data was extracted
and presented in tabular form. The categories depicted
included study location, survey method, number of re-
spondents and response rate, percentage in favour of
prescription rights, and percentage opposed to prescription
rights. Data pertaining to chiropractic prescribing rights in
Switzerland was presented in a separate table, with the last
category consisting of attitudes toward existing prescription
rights and its application in practice.Table 2 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Articles of any type of
prospective research design,
• Articles published in trade
magazines,
• Articles published in English, • Letters to the Editor,
Commentaries,
• Articles published in a
peer-reviewed journal, and
• Articles not published in
English, and/or
• Articles that contain data on
chiropractors’ opinions toward
medication prescription rights.
• Articles not specific to the
topic of chiropractors’
opinions toward medication
prescription rights.Synthesis of the results




Thirty-three potential articles were identified through
the literature searches and retrieved for full paper re-
view. Twenty-two of these articles were identified from
literature searches, eight from reference searching, two
from secondary searching of unpublished literature,
and one from personal contact with authors known to
have expertise in this area.
Included articles
A total of seven articles, all surveys, were deemed in-
cludable in the review [15,20-25]. Reasons for exclusion
of the 26 excluded papers are presented in Table 3, and
a summary of the included non-Swiss and Swiss articles
is presented in Tables 4 and 5, respectively.
Main outcomes
Based on the literature to date there is a general split in
opinion among chiropractors regarding the right to pre-
scribe drugs in chiropractic practice. This split in opinion
is most pronounced in countries where chiropractors are
not currently licensed to prescribe medications (Table 4).
For instance, in a 1990 survey involving members of the
Federal Branch of the Australian Chiropractors’Association
[20], 42% of respondents felt that prescription drugs should
“never” be used in chiropractic practice. This was com-
pared to 58% who believed that prescription drugs
should “frequently” (2%), “sometimes” (31%), or at least
“rarely” (25%) be used. In 1997, Jacobson and Gemmell
[21] conducted a survey of all registered chiropractors
in Oklahoma, USA. Out of 304 total respondents, 54%
felt that chiropractors should have the right to prescribe
prescription drugs. Similarly, McDonald et al. [23] sur-
veyed chiropractors from various North American regions
and found that 54.3% of respondents felt they should be
permitted to write OTC prescriptions, while a nearly equal
number (51.2%) were opposed to prescription-based
musculoskeletal medicines (e.g. muscle relaxants). In
the United Kingdom, Wilson [22] and Pollentier andTable 3 Reasons for excluding papers from this review
Reason Reference
Commentary from a trade magazine [26-29]
Not about chiropractors’ attitudes toward
prescribing rights in chiropractic
[11,30-36]
Commentary from a peer-reviewed publication [3-10]
Letter to the Editor [12-14]
Not published in a peer-reviewed journal [2,37,38]















Australia Postal 339 respondents,
20% response rate
• 2% of respondents felt that prescription
drugs should “frequently” be used in
chiropractic practice, 31% indicated
“sometimes,” and 25% indicated these
should be used “rarely”
• 42% of respondents felt that
prescription drugs should “never”
be used in chiropractic practice
• Of those supportive of drugs, 84%
favoured NSAIDs, 80% favoured analgesics,
and 74% favoured muscle relaxants
• 13% indicated that they “never”
advise acute patients to take
analgesics
• 59% of all respondents indicated that
they advise acute patients to take
analgesics “always,” “usually,” or
“sometimes,” while an additional 28% do
so at least “rarely”
• 27% indicated that they “never”
suggest acute patients take NSAIDs
(while the remaining 7% of
respondents queried the meaning
of the abbreviation ‘NSAIDs’)
• 42% of all respondents indicated that
they suggest acute patients take NSAIDs
“always,” “usually,” or “sometimes,” while
an additional 24% do so at least “rarely”
• Of those supportive of drugs,
65% were opposed to chiropractors
prescribing antibiotics, 71% to




Oklahoma, USA Postal 304 respondents,
49% response rate
• 54% favoured prescription rights for
chiropractors
• 28% of respondents “never”
recommended OTC drugs to patients
in their chiropractic practice
• 13% of respondents “often” recommended
OTC drugs to patients in their chiropractic
practice, 26% did so “sometimes,” and 33%







• 36% of respondents felt that chiropractors
should be allowed to prescribe medications
on a restricted basis (e.g. mild analgesics,
NSAIDs, and muscle relaxants)








• 54% favoured chiropractors writing OTC
drug prescriptions
• 51% were opposed to chiropractors
writing prescriptions for musculoskeletal
medicines (e.g. muscle relaxants)
• 89% were opposed to chiropractors










• 28% of respondents felt it would be
beneficial if chiropractors were allowed
to prescribe medication on a restricted
basis (e.g. mild analgesics, NSAIDs, and
muscle relaxants)
• 59% felt that limited prescription
rights would not be beneficial
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respectively, were in support of chiropractors prescribing
medications on a restricted basis (e.g. mild analgesics,
NSAIDs, and muscle relaxants). However, Pollentier and
Langworthy found that 59% of their respondents did not
consider this proposition to be beneficial [24]. Therefore
based on those surveyed, chiropractors in Australia, North
America, and the United Kingdom appear to be divided in
their attitudes toward drug prescription rights.
Conversely, the general attitude of chiropractors who
are already licensed to prescribe medications is much dif-
ferent (Table 5). Since 1995, chiropractors in Switzerland
have been able to prescribe from a limited formulary of
OTC drugs and topical medications (see Table 1). In 1999,Robert [15] undertook a survey of all Swiss chiropractors
to assess their general attitude towards this limited
privilege, as well as the possibility of extending it to in-
clude some prescription-based medicines. Of 126 re-
spondents, 61% indicated that they prescribed OTC
medications (i.e. analgesics and NSAIDs) to their patients;
and 82% considered these limited privileges an advantage
for the chiropractic profession in Switzerland. More-
over, 76% wanted these privileges extended to include
some prescription-based analgesic and muscle relaxant
medications. In 2010, Wangler et al. [25] conducted a
survey of all chiropractors in Berne, Switzerland. Similar
to the Robert [15] survey, the majority of respondents
(72%) agreed that the ability to prescribe OTC analgesic






and response rate (%)
Attitudes toward existing drug prescription rights and its application
in practice
Robert [15], 2003 Switzerland Postal 126 respondents,
51% response rate
• 61% of respondents prescribe OTC medications (i.e. analgesics and NSAIDs)
to their patients
• 82% consider these limited prescribing rights a privilege for the chiropractic
profession in Switzerland
• 76% would like this privilege extended to include some prescription-based
analgesic and muscle relaxant medications




• 72% of respondents agreed that the ability to prescribe OTC analgesic and
anti-inflammatory medications was an advantage for the chiropractic
profession in Switzerland
• 58% would like this privilege extended to include some additional
prescription-based NSAIDs, muscle relaxants, and analgesics
• 41% perceived medication as a necessary component of treatment (e.g. to
help patients who cannot sleep because of pain and to speed up recovery)
• 91% agreed that continuing education in pharmacology was necessary
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chiropractors in Switzerland, while 58% also wanted this
privilege extended to include some additional prescription-
based NSAIDs, muscle relaxants, and analgesics. Fewer
respondents (41%) perceived medication as a necessary
component of chiropractic treatment, mainly using them
to help patients who cannot sleep because of pain and/or
to help speed up recovery. Finally, a large majority (91%)
agreed that continuing education in pharmacology was a
necessary component to the privilege of drug prescription
in chiropractic. Overall the general attitude of chiropractors
surveyed in Switzerland appears to be more favourable to-
wards drug prescription when compared to chiropractors
surveyed in other regions.
The results of three of the surveys indicate that among
chiropractors who are supportive of prescribing rights, a
limited number of OTC and/or prescription medications
are favoured (see Table 4). For example, of Australian
chiropractors who were supportive of drug prescription,
84% favoured NSAIDs, 80% analgesics, and 74% muscle
relaxants [20]. This view was also supported by chiro-
practors in Oklahoma [21] where more than half (56.7%)
of those in favour of prescribing rights indicated that
only a select group of drugs such as analgesics, anti-
inflammatories, and muscle relaxants, should be per-
mitted for prescription by chiropractors. In North
America [23], an overwhelming majority (88.6%) of
respondents, whether supportive of drug prescription
by chiropractors or not, were opposed to full prescribing
rights (i.e. the ability of chiropractors to write prescrip-
tions for any and all medicines, including controlled
substances). As such, whether practising in Switzerland
or elsewhere, chiropractors with attitudes favourable
toward drug prescription surveyed in these regions
tend to prefer limited prescribing rights within a mus-
culoskeletal scope of practice.Two of the surveys from this review detail the use of
OTC medications in chiropractic practice (see Table 4).
In Oklahoma, USA [21], for example, 28% of survey
respondents indicated that they “never” recommended
non-prescription drugs to their patients. However,
72% admitted that they did so “often” (12.9%), “sometimes”
(26.5%) or at least “seldomly” (32.6%). Australian chiro-
practors’ behaviours were similar when it came to the
use of OTC medicines [20]. Thirteen percent of respon-
dents “never” advised acute patients to take analgesics,
while 59% did so “always,” “usually,” or “sometimes,” and
an additional 28% advised these drugs at least “rarely.”
Regarding NSAIDs, 27% “never” suggested these to acute
patients, while 42% “always,” “usually,” or “sometimes” did,
and an additional 24% suggested NSAIDs at least “rarely.”
Thus, although chiropractors in these regions appear to
be divided in their attitudes toward prescribing rights in
general, many often still recommend OTC medications
to patients in practice.
Discussion
The main finding of this narrative review was that based on
the literature to date there is a general split in chiropractors’
opinions regarding drug prescription rights in chiropractic.
For instance, from published surveys [20-24] of chiroprac-
tors in Australia, the United States, Canada, Mexico, and
the United Kingdom, no more than 58% of respondents
were in favour of chiropractic prescribing rights and no
less than 42% were opposed. In some of these studies, this
split was nearly even [21,23]. In Switzerland on the other
hand, the majority (72% to 82%) perceived their prescrip-
tive privileges as an advantage for the profession [15,25],
and between 58% and 76% wanted to see these privileges
extended to include some additional prescription-based
analgesic and muscle relaxant medications. These divided
attitudes within the chiropractic profession stand in stark
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care professions who are unified on this issue [39-41].
To better understand this chiropractic split, therefore,
the implications of drug prescription for the profession
must first be considered.
There are some concerns that are often mentioned by
authors who are against chiropractors gaining access to
prescription rights. One of the most pressing concerns is
the lack of chiropractic education and training in pharma-
cology and toxicology [7,8,10]. In addition, there is concern
about the risk of losing chiropractic’s distinct professional
identity [4-9]. The first concern is legitimate, in that the
basic chiropractic educational curriculum contains only
12 hours of coursework in pharmacology [42], although
the actual number of course hours may vary from edu-
cational institution to institution. Nevertheless, further
undergraduate and/or post-graduate education and training
would be required for those in the profession wishing to
prescribe medications. As for chiropractic’s identity, many
have argued that the profession has always lacked a clear
identity, resulting in its failure to establish full cultural
authority and respect within mainstream society [43-45].
Some of these same authors [43] have also warned of the
U.S. osteopathic experience, where given the option of
prescribing drugs and using other more invasive interven-
tions, the role of manipulative therapy has diminished
(and nearly vanished) from this profession.
Another issue to consider is that of interprofessional
relations. Some have argued that the inclusion of prescrip-
tion drugs within the chiropractic scope of practice would
negatively impact relationships with the medical profession
[46]. However, if working as part of a collaborative team
this expanded role for chiropractors may be supported by
physicians, particularly if limited to treating musculoskeletal
conditions [30,47]. In Switzerland, chiropractors are among
one of five government-recognized medical professions
(i.e. human medicine, chiropractic medicine, veterinary
medicine, dentistry, and pharmacology) [16,30]. Swiss
chiropractors have limited prescribing rights and are
integrated and accepted by the medical community [30].
In the United Kingdom, the recent provision of limited
prescribing rights to physiotherapists and podiatrists has
also been met with support from medical doctors [18].
One important published commentary on this topic
was written in 1999 by Australian chiropractor, Dr. Jennifer
Jamison [10]. In the article, Dr. Jamison highlighted both
the potential benefits and detriments of drug prescription
in chiropractic. On one hand, limited prescribing rights
would give chiropractors and their patients more direct
access to prescription analgesic and anti-inflammatory
medications, allowing for a more complete management
approach to patients with musculoskeletal conditions, a
statement supported by some evidence [48,49]. Unless re-
stricted to certain medications, these privileges could alsogive chiropractors access to antibiotics and other drugs
used in treating chronic complaints (e.g. hypertension,
anxiety, and depression). Conversely, these same privileges
could fundamentally change the focus of chiropractic care
from health to disease, increase the burden of practitioner
responsibility in terms of recognizing and monitoring drug
side effects, and create the need for additional chiropractic
undergraduate training and practitioner self-education [10].
Further implications would include necessary regulatory
and legislative changes, consideration of legal and ethical
issues, and increases to chiropractic malpractice/liability
insurance coverage [47].
The aforementioned split in opinion over chiropractic
prescribing rights could be reflective of differences in
philosophical orientation. For example, McDonald et al.
[23] found that out of 647 respondents, 34.3% of North
American chiropractors surveyed classified themselves as
practising within a “broad” scope of practice (i.e. the often
described chiropractic ‘mixer’), 19.3% were “focused scope”
(or the often described ‘straight’ chiropractors), and
the remaining 46.4% identified themselves somewhere
inbetween. Among the broad scope respondents, more
than three quarters (77.1%) believed that chiropractors
should be permitted to prescribe OTC medications, while
only 17.6% of the focused group felt the same way. These
philosophical divisions within the chiropractic profession
have also been shown by others [50].
The split in opinion over prescribing rights could also
possibly be explained by the fact that, at least in the
McDonald et al. survey, North American chiropractors
as a group were of the opinion that only 39.8% of all
pharmaceutical prescriptions filled annually were clin-
ically beneficial [23]. This type of attitude might again
be more reflective of philosophical orientation, versus
that of evidence-based practice. Regardless, as suggested by
McDonald et al. [23], the legal right to prescribe certain
drugs to patients in chiropractic practice would include the
right of un-prescribing these same drugs. For example
if given limited prescriptive authority, this would en-
able chiropractors to advise patients against overuse
and over-reliance on medications such as analgesics,
NSAIDs, and muscle relaxants [25,46]. Therefore, chi-
ropractors may not all agree on prescribing rights in
chiropractic, but perhaps all could unite on the issue of
prescribing rights related to counselling patients on
medication use?
Another finding of this review was that despite the
profession’s split over the right to prescribe drugs, many
chiropractors often still recommend OTC medications to
their patients. For instance, while only 54% of respondent
chiropractors in Oklahoma, USA [21] were supportive of
prescribing rights, 72% indicated that they recommended
non-prescription drugs with variable frequency in clinical
practice. Similarly, Australian chiropractors [20] were split
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spondents still advised acute patients to take OTC analgesic
and NSAID medications to some extent, respectively.
Interestingly, chiropractors in Switzerland are licensed
to prescribe OTC medications in practice, yet they appear
to do so with less frequency than their international
colleagues. For example, when asked how often Swiss
chiropractors prescribed analgesics, NSAIDs, and muscle
relaxants [25], respondents indicated that only 60%,
55.9%, and 21.5% did so, respectively. Similarly, as part of
a 2009 ‘Job Analysis’ survey Humphreys et al. [30] asked
Swiss chiropractors how often they prescribed pain medi-
cation in practice. The majority (70%) indicated that they
did so for between 0% and 25% of patients, with an
additional 15% prescribing these for 26% to 50% of their
patients. Only 2% of Swiss chiropractors prescribed pain
medication for 51% to 75% of patients, and none (0%) did
so for between 76% and 100% of their patients. Therefore,
although Swiss chiropractors are generally more positive
in their attitudes toward drug prescription, the majority
utilize this privilege on a selective basis with their patients.
This reduced usage could possibly be explained by differ-
ences in training and continuing education, particularly in
pharmacology, that Swiss chiropractors receive [25,30]
when compared to others in the profession [42].
Aside from Switzerland, the second jurisdiction world-
wide where chiropractors can currently gain licensure to
prescribe medications is in New Mexico, USA. Since March
31, 2009, chiropractors certified as ‘advanced practice chiro-
practic physicians’ have been eligible to register for limited
prescriptive authority through the New Mexico Board of
Chiropractic Examiners [17]. The National University of
Health Sciences (in Chicago, Illinois) currently offers a
two-year Master of Science degree in ‘Advanced Clinical
Practice’ which, among other courses, offers further train-
ing in pharmacology [51], allowing chiropractors to apply
for ‘advanced practice’ status in the state of New Mexico,
along with the use of its limited formulary (see Table 1).
Those chiropractors in New Mexico wishing to renew
their advanced practice certification must do so annually,
completing an additional 10 hours of continuing education
over-and-above their required hours for general chiro-
practic licensure in pharmacology, toxicology, and/or
medication administration relevant to the current
formulary [17]. Regarding drug prescription utilization, 146
(or approximately 30%) of the 480 licensed chiropractors
currently practising in New Mexico are certified as ad-
vanced practice chiropractic physicians [52].
In Switzerland, there is also general support for expand-
ing the current chiropractic formulary to include additional
prescription-based analgesics (e.g. opioids) and muscle
relaxants. In fact, the Swiss Chiropractic Association
has recently put forth a proposal to the Swiss government,
requesting this expansion; and it has been successful[53]. In New Mexico, chiropractors have similarly
made attempts at expanding their current formulary
(to include additional prescription drugs, as well as
drugs to be administered by injection), but without suc-
cess in large part due to opposition from the ICA [54].
This push for expanded prescribing rights in New Mexico
appears to be motivated by a desire to train advanced
practice chiropractors to operate as ‘primary care physi-
cians’, particularly in rural areas where there is a current
shortage of general medical physicians [36].
Concerning the issue of full prescribing rights, how-
ever, evidence from the reviewed literature suggests
that chiropractors are generally opposed [20,21,23]. In
the Jamison survey [20], for example, of the Australian
chiropractors who were supportive of drugs (i.e. NSAIDs,
analgesics, and muscle relaxants) there was almost equal op-
position to the use of medications for non-musculoskeletal
conditions; indeed, 65% were opposed to chiropractors
prescribing antibiotics, 71% were opposed to steroid
prescription, and 74% were opposed to anti-hypertensive
prescription by chiropractors. Similarly in North America
[23], despite a near even split on attitudes toward limited
prescribing rights, a large majority (88.6%) of respondents
were opposed to chiropractors having full prescribing rights
(i.e. the ability to write prescriptions for any and all
medicines). As such, previous attempts at expanding the
New Mexico chiropractic scope of practice to beyond a lim-
ited number of medications [36,54], appears to be contrary
to the general attitude of many others in the profession.
Limitations
This review has several limitations. First, the literature
search was limited to three databases, included only arti-
cles written in English, and excluded non-peer reviewed
and/or non-scholarly publications such as those from
trade magazines. Therefore, other pertinent articles or
commentaries on the topic of drug prescription in chiro-
practic may have been omitted. Second, all of the seven
papers included in this review were surveys. However,
this study sought information about chiropractors’ general
attitudes and opinions regarding drug prescription in
chiropractic, and as such inclusion of this study design
was appropriate. Third, several of the surveys reviewed
were limited by low response rates [15,20-24]. Moreover,
none of the authors from these surveys compared re-
spondents with non-respondents. As such, if there were
systematic differences as opposed to chance differences
between respondent and non-respondent chiropractors
surveyed in a given region, the results obtained would not
be generalizable to the entire population of chiropractors in
that region [55]. Therefore outside of Berne, Switzerland,
the general attitude of chiropractors toward drug prescrip-
tion in chiropractic remains somewhat in question. Because
of this, further surveys and/or qualitative research studies
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chiropractors toward drug prescription in chiropractic
both locally and internationally. In future surveys,
non-response bias should be investigated, particularly
if response rates obtained from these surveyed populations
are low. Finally, when compared to other research designs
(e.g. systematic reviews), narrative reviews of the literature
are more susceptible to bias [56].
Conclusions
This review identified seven surveys pertinent to the topic
of chiropractors’ attitudes toward drug prescription in
chiropractic published in the peer-reviewed literature.
Of these, there was a general split in opinion concerning
the right to prescribe medications. In jurisdictions where
chiropractors are currently licensed to prescribe a limited
number of medications, such as in Switzerland, the major-
ity perceived this right as an advantage for the profession.
Moreover, continuing education in pharmacology was
viewed as a necessary component of this privilege. Future
surveys and/or qualitative studies of chiropractors’ attitudes
toward gaining similar privileges would be timely.
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Abbreviations
ACA: American chiropractic association; CINAHL: Cumulative index to nursing
and allied health literature; ICA: International chiropractors association;
ICL: Index to chiropractic literature; MeSH: Medical subject heading;
NSAIDs: Non-steroidal anti-inflammatory drugs; OTC: Over the counter;
US: United States; USA: United States of America; WFC: World federation of
chiropractic.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PCE performed the literature search and drafted the initial manuscript. KJS
and PCE each reviewed the literature. Both authors also drafted, revised, and
approved the final manuscript.
Author details
1Private Practice, 201C Preston Parkway, Cambridge, ON N3H 5E8, Canada.
2Division of Graduate Education and Research, Canadian Memorial
Chiropractic College, 6100 Leslie Street, Toronto, ON M2H 3 J1, Canada.Received: 31 December 2013 Accepted: 13 September 2014References
1. World Federation of Chiropractic: WFC policy statement: use of prescription
drugs. [http://www.wfc.org/website/docs/992003143539.PDF] [Accessed 28
October 2013].
2. Northstar Research Partners & Manifest Communications: Consultation on
identity: quantitative research findings. [http://www.wfc.org/website/images/
wfc/docs/wfc_report_january2005_05.ppt] [Accessed 9 October 2013].
3. Barge FH: Philosophy, power, politics, drugs. ICA ICA Rev 1989, 45:7.
4. Luedtke KL: ACA goes on record in master plan: no drugs, no surgery.
J Chiropr 1989, 26:72–73.
5. Kern DP: Should DCs prescribe drugs? ICA Rev 1989, 45:11–13.
6. Hagen BB: Should DCs prescribe drugs? ICA Rev 1989, 45:13.
7. Williams SE: Should DCs prescribe drugs? ICA Rev 1989, 45:15–16.
8. Clum G: Should DCs prescribe drugs? ICA Rev 1989, 45:17–19.
9. Asplin KH: Should DCs prescribe drugs? ICA Rev 1989, 45:19.
10. Jamison JR: Point of view: is there a role for the prescription of
medication by chiropractors? Australas Chiropr Osteopath 1999, 8:60.
11. Crawford JP: Pharmacological modulation of localized inflammatory
reactions: the nonsteroidal anti-inflammatory drug as an adjunct to
therapy. J Manipulative Physiol Ther 1988, 11:17–23.
12. Croft AC: Letter to the Editor. J Manipulative Physiol Ther 1988, 11:441–442.
13. Falco R: Letter to the Editor. J Manipulative Physiol Ther 1988, 11:333.
14. DeWitt EL: Letter to the Editor. J Manipulative Physiol Ther 1989, 12:63.
15. Robert J: The multiple facets of the Swiss chiropractic profession.
Eur J Chiropr 2003, 50:199–210.
16. Peterson CK: Personal communication. 22 October 2013.
17. New Mexico Regulation & Licensing Department: New Mexico
administrative code: chiropractic advanced practice certification
registry. [http://www.rld.state.nm.us/uploads/files/2010%20APC%
20Formulary.pdf] [Accessed 9 October 2013].
18. Chartered Society of Physiotherapy: Landmark decision gives UK physios a
world first in prescribing rights. [http://www.csp.org.uk/news/2012/07/24/
landmark-decision-gives-uk-physios-world-first-prescribing-rights#!]
[Accessed 2 October 2013].
19. Nursing Careers & Allied Health: Australian physiotherapists want prescribing
rights. [http://www.ncah.com.au/news-events/australian-physiotherapists-want-
prescribing-rights/1874/] [Accessed 2 October 2013].
20. Jamison JR: Chiropractic in the Australian health care system: the
chiropractors’ comment on drug therapy. Chiropr J Aust 1991, 21:53–55.
21. Jacobson BH, Gemmell HA: A survey of chiropractors in Oklahoma.
J Chiropr Educ 1999, 13:137–142.
22. Wilson FJH: A survey of chiropractors in the United Kingdom. Eur J
Chiropr 2003, 50:185–198.
23. McDonald WP, Durkin KF, Pfefer M: How chiropractors think and practice: the
survey of North American chiropractors. Semin Integr Med 2004, 2:92–98.
24. Pollentier A, Langworthy JM: The scope of chiropractic practice: a survey
of chiropractors in the UK. Clin Chiropr 2007, 10:147–155.
25. Wangler M, Zaugg B, Faigaux E: Medication prescription: a pilot survey of
Bernese doctors of chiropractic practicing in Switzerland. J Manipulative
Physiol Ther 2010, 33:231–237.
26. Williams E: Ed Williams, D.C.: chiropractic and over the counter drugs.
Am Chiropr 1986, October:40,42–43.
27. Carlucci JF: Defining the use of pharmaceuticals. Dig Chiropr Econ 1988,
30:124.
28. Simonetti SJ: No place for drugs in chiropractic. Todays Chiropr 1995,
24:11–12.
29. Arvay JS: Drawing the battle lines. Todays Chiropr 1998, 27:12–13.
30. Humphreys BK, Peterson CK, Muehlemann D, Haueter P: Are swiss
chiropractors different than other chiropractors? Results of the job
analysis survey 2009. J Manipulative Physiol Ther 2010, 33:519–535.
31. Miglis MF: Letter to the Editor. J Manipulative Physiol Ther 1989, 12:239.
32. Jamison JR, Shadwell SJ, Foley NG, Leskovec K: Drug usage by
patients attending chiropractic clinics. J Manipulative Physiol Ther
1988, 11:474–479.
33. Jamison JR: Drugs in chiropractic clinical practice: contemplating the
variables which influence utility. J Manipulative Physiol Ther 1991,
14:255–261.
Emary and Stuber Chiropractic & Manual Therapies 2014, 22:34 Page 9 of 9
http://www.chiromt.com/content/22/1/3434. Aldred E, McCarthy P: A practical approach to recognising the potential
for and reducing the likelihood of adverse drug reactions. Clin Chiropr
2010, 13:280–288.
35. Smith M, Bero L, Carber L: Could chiropractors screen for adverse drug events
in the community? Survey of US chiropractors. Chiropr Osteopat 2010, 18:30.
36. Lehman JJ, Suozzi PJ, Simmons GR, Jegtvig SK: Patient perceptions in New
Mexico about doctors of chiropractic functioning as primary care providers
with limited prescriptive authority. J Chiropr Med 2011, 10:12–17.
37. Ebrall PS: Section One: Listing of Motions. In The Proceedings of the Ninth
Annual World Congress of Chiropractic Students: 28 September to 2 October
1988; Melbourne. Edited by Ebrall PS. Bundoora: Pit Press; 1988:10.
38. British Chiropractic Association: Limited prescribing rights. In Touch
[Newsletter] 2009, 142:4–5.
39. Mason A, Mason J: Optometrist prescribing of therapeutic agents:
findings of the AESOP survey. Health Policy 2002, 60:185–197.
40. George J, Pfleger D, McCaig D, Bond C, Stewart D: Independent prescribing
by pharmacists: a study of the awareness, views and attitudes of Scottish
community pharmacists. Pharm World Sci 2006, 28:45–53.
41. Courtenay M, Carey N, Burke J: Independent extended and supplementary
nurse prescribing practice in the UK: a national questionnaire survey.
Int J Nurs Stud 2007, 44:1093–1101.
42. World Health Organization: WHO guidelines on basic training and safety
in chiropractic. [http://apps.who.int/medicinedocs/documents/s14076e/
s14076e.pdf] [Accessed 6 November 2013].
43. Nelson CF, Lawrence DJ, Triano JJ, Bronfort G, Perle SM, Metz RD,
Hegetschweiler K, LaBrot T: Chiropractic as spine care: a model for the
profession. Chiropr Osteopat 2005, 13:9.
44. Murphy DR, Schneider MJ, Seaman DR, Perle SM, Nelson CF: How can
chiropractic become a respected mainstream profession? The example
of podiatry. Chiropr Osteopat 2008, 16:10.
45. Erwin MW, Korpela AP, Jones RC: Chiropractors as primary spine care providers:
precedents and essential measures. J Can Chiropr Assoc 2013, 57:285–291.
46. The Chiropractic Report: The prescription drug debate. Should the chiropractic
profession remain drug free? [https://www.chiropracticreport.com/index.
php/past-issues/view_document/68-no-6-the-prescription-drug-debate]
[Accessed 23 July 2014].
47. The College of Family Physicians of Canada: Position statement. Prescribing
rights for health professionals. [http://www.cfpc.ca/uploadedFiles/Resources/
Resource_Items/CFPC20Position20Statement20Prescribing20Rights20
January202010.pdf] [Accessed 23 September 2013].
48. Chou R, Qaseem A, Snow V, Casey D, Cross T Jr, Shekelle P, Owens DK:
Diagnosis and treatment of low back pain: a joint clinical practice
guideline from the American College of Physicians and the American
Pain Society. Ann Intern Med 2007, 147:478–491.
49. Chou R, Huffman LH: Medications for acute and chronic low back pain:
a review of the evidence for an American Pain Society/American College of
Physicians Clinical Practice Guideline. Ann Intern Med 2007, 147:505–514.
50. Biggs L, Hay D, Mierau D: Canadian chiropractors’ attitudes towards
chiropractic philosophy and scope of practice: implications for the
implementation of clinical practice guidelines. J Can Chiropr Assoc
1997, 41:145–154.
51. National University of Health Sciences: Master of Science – Advanced Clinical
Practice. [http://www.nuhs.edu/academics/college-of-continuing-education/
masters-degrees/advanced-clinical-practice/] [Accessed 20 October 2013].
52. Doggett W: Personal communication. 23 October 2013.
53. Peterson CK: Personal communication. 23 July 2014.
54. International Chiropractors Association: ICA News – August 2013.
[http://www.thechiropracticchoice.com/thechiropracticchoice.com/
NEW-MEXICO-COURT-OF-APPEALS-SETS-ASIDE%20IMPROPERLY-
ENACTED-CHIROPRACTIC-RULE.pdf] [Accessed 12 November 2013].
55. Greenhalgh T: How to Read a Paper: The Basics of Evidence-Based Medicine.
4th edition. Chichester: John Wiley & Sons; 2010.
56. Haneline MT: Evidence-Based Chiropractic Practice. Sudbury: Jones and
Bartlett; 2007.
doi:10.1186/s12998-014-0034-7
Cite this article as: Emary and Stuber: Chiropractors’ attitudes toward
drug prescription rights: a narrative review. Chiropractic & Manual
Therapies 2014 22:34.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
